tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pelthos Therapeutics completes merger with Channel Therapeutics
PremiumThe FlyPelthos Therapeutics completes merger with Channel Therapeutics
1M ago
Ligand Pharma Elects Board Members at Annual Meeting
Premium
Company Announcements
Ligand Pharma Elects Board Members at Annual Meeting
2M ago
Ligand price target raised to $145 from $142 at Oppenheimer
Premium
The Fly
Ligand price target raised to $145 from $142 at Oppenheimer
3M ago
Ligand sees FY25 adjusted EPS $6.00-$6.25, consensus $6.11
PremiumThe FlyLigand sees FY25 adjusted EPS $6.00-$6.25, consensus $6.11
3M ago
Ligand reports Q1 adjusted EPS $1.33, consensus $1.21
Premium
The Fly
Ligand reports Q1 adjusted EPS $1.33, consensus $1.21
3M ago
LGND Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LGND Earnings this Week: How Will it Perform?
3M ago
Ligand price target raised to $155 from $143 at RBC Capital
PremiumThe FlyLigand price target raised to $155 from $143 at RBC Capital
5M ago
Ligand Pharmaceuticals Reports Strong 2024 Financial Growth
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong 2024 Financial Growth
5M ago
Ligand reports Q4 adjusted EPS $1.27, consensus $1.19
Premium
The Fly
Ligand reports Q4 adjusted EPS $1.27, consensus $1.19
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100